Glibenclamide: Difference between revisions
Created page with "Glibenclamide (INN), also known as glyburide (USAN), is a second-generation sulfonylurea oral hypoglycemic agent used in the management of type 2 diabetes mellitus. It acts primarily by stimulating insulin release from the pancreatic beta cells and is one of the most potent and longest-acting drugs in its class." |
(No difference)
|
Latest revision as of 10:11, 2 December 2025
Glibenclamide (INN), also known as glyburide (USAN), is a second-generation sulfonylurea oral hypoglycemic agent used in the management of type 2 diabetes mellitus. It acts primarily by stimulating insulin release from the pancreatic beta cells and is one of the most potent and longest-acting drugs in its class.